Cargando…
Changes in health‐related quality of life with long‐term eltrombopag treatment in adults with persistent/chronic immune thrombocytopenia: Findings from the EXTEND study
Patients with persistent/chronic immune thrombocytopenia (cITP) have low platelet counts, increased risk of bleeding and bruising, and often suffer from reduced health‐related quality of life (HRQoL). cITP treatments may either improve HRQoL by increasing platelet counts or decrease it because of si...
Autores principales: | Khelif, Abderrahim, Saleh, Mansoor N., Salama, Abdulgabar, Portella, Maria do Socorro O., Duh, Mei Sheng, Ivanova, Jasmina, Grotzinger, Kelly, Roy, Anuja N., Bussel, James B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587804/ https://www.ncbi.nlm.nih.gov/pubmed/30417939 http://dx.doi.org/10.1002/ajh.25348 |
Ejemplares similares
-
Treatment of immune thrombocytopenia with eltrombopag in patients who had and who had not received prior rituximab: post‐hoc analysis of the EXTEND study
por: Meyer, Oliver, et al.
Publicado: (2021) -
Cost-consequence model comparing eltrombopag and romiplostim in pediatric patients with chronic immune thrombocytopenia
por: Tremblay, Gabriel, et al.
Publicado: (2018) -
Autoimmune Thrombocytopenia Complicated by EDTA- and/or Citrate-Dependent Pseudothrombocytopenia
por: Salama, Abdulgabar
Publicado: (2015) -
Eltrombopag in long‐term management of pediatric thrombocytopenia
por: Shah, Sanjay J., et al.
Publicado: (2018) -
Oxidative Stress Is Predominant in Female but Not in Male Patients with Autoimmune Thrombocytopenia
por: Kamhieh-Milz, Julian, et al.
Publicado: (2014)